1.A clinical audit of the diagnosis and management of chronic kidney disease in a primary care clinic
Mohamed Syarif Mohamed Yassin ; Jazlan Jamaluddin ; Siti Nuradliah Jamil ; Mohd Azzahi Mohamed Kamel ; Mohamad Ya&rsquo ; akob Yusof
Malaysian Family Physician 2021;16(3):68-76
		                        		
		                        			
		                        			Introduction: This audit was performed to monitor the diagnosis and management of chronic kidney disease (CKD) according to the clinical practice guidelines (CPGs) of CKD 2018 in a primary care clinic.
Methods: Patients who attended the clinic from April to June 2019 and fulfilled the diagnosis of CKD were included in this study, except for those diagnosed with a urinary tract infection, pregnant women and those on dialysis. These criteria were set based on the CPGs. The standards were set following discussions with the clinic team members with reference to local guidelines, the 2017 United Kingdom National CKD audit and other relevant studies.
Results: A total of 384 medical records were included in this audit. Overall, 5 out of 20 criteria for processes and 3 of 8 clinical outcomes for CKD care did not meet the set standards. These included the following: documentation of CKD classification based on albumin category (43.8%); CKD advice (19.0%); dietitian referral (9.1%); nephrologist referral (45.5%); haemoglobin level monitoring (65.7%); overall blood pressure (BP) control (45.3%); BP readings for diabetic kidney disease (DKD) and non-DKD with > 1 g/day of proteinuria (≤ 130/80 mmHg, 37.0%); eGFR reduction of < 25% over the past year (77.2%). Identified problems included the absence of a CKD registry, eGFR and albuminuria reports, and a dedicated team, among other factors.
Conclusions: Overall, 8 out of 28 criteria did not meet the standards of CKD care set for this audit. The problems identified in this audit have been addressed. Moreover, strategies have also been formulated to improve the diagnosis and management of CKD in this clinic.
		                        		
		                        		
		                        		
		                        	
2.Effects of Gelam Honey on Oxidative Stress in Lung Cancer Cells
Goon JA ; Gunasekaran G ; Muhamad Fitri CA ; Chandrashegkar S ; Hajar Amalnina AB ; Raishan S ; Nurul Faiznani Z ; Ismail NAS ; Mohd Yusof YA
Medicine and Health 2017;12(2):202-209
		                        		
		                        			
		                        			Gelam  honey  was  reported  to  exhibit  anti-oxidative,  anti-tumour  and  anti-inflammatory properties against many types of cancer. The main aim of the present study was to evaluate the effect of Gelam honey on the oxidative stress level of human  lung  cancer  cells.  IC50  of  Gelam  honey  was  identified  by  treating  A549 cells  with  different  doses  of  honey  (50-200  mg/ml).  The  cells  were  divided  into four groups and induced with stress using hydrogen peroxide (H2O2) accordingly: control,  H2O2,  Gelam  honey,  H2O2  +  Gelam  honey.  After  24  hrs  of  treatment, oxidative  stress  markers  such  as  malondialdehyde  (MDA)  and  protein  carbonyl, were  determined.  Induction  of  oxidative  stress  significantly  increased  the  levels of  MDA  (p<0.05)  but  had  no  effect  on  protein  carbonyl  levels.  Treatment  with Gelam  honey  was  found  to  reduce  MDA  levels  (p<0.05)  in  A549  cells  exposed to  H2O2  but  had  no  effect  on  the  level  of  protein  carbonyl.  Interestingly,  Gelam honey treatment alone had no effects on the levels of MDA and protein carbonyl. In conclusion, Gelam honey reduces lipid peroxidation but not protein oxidation in human lung cancer cells subjected to oxidative stress.
		                        		
		                        		
		                        		
		                        	
3.Apoptosis changes and SA-beta galactosidase expression in stress-induced premature senescence (SIPS) model of human skin fibroblasts.
Abdul Rahim N ; Makpol S ; Chua KH ; Yusof YA ; Top GM ; Ngah WZ
The Medical Journal of Malaysia 2008;63 Suppl A():71-72
		                        		
		                        			
		                        			Stress-induced premature senescence (SIPS) model is in vitro model of cellular aging. In this study, apoptosis was evaluated in SIPS model and in replicative senescent fibroblasts. We also compared the activity of senescence-associated beta-galactosidase (SA-beta gal) as a biomarker of cellular aging. Our results suggested that SIPS model and senescent fibroblasts might share similar mechanism of aging and apoptosis pathway.
		                        		
		                        		
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail